SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR
Viruses · 2024
DOI: 10.3390/v16071008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Frederique Laprise und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada. Hauptthemen laut MEDLINE: Receptors, Polymeric Immunoglobulin, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Canadian Institute of Health Research Canada Graduate Scholarship—Master’s program.
Abstract (Originalsprache)
SARS-CoV-2 is a highly pathogenic respiratory virus that successfully initiates and establishes its infection at the respiratory mucosa. However, little is known about how SARS-CoV-2 antagonizes the host’s mucosal immunity. Recent findings have shown a marked reduction in the expression of the polymeric Ig receptor (pIgR) in COVID-19 patients. This receptor maintains mucosal homeostasis by transporting the dimeric IgA (dIgA) and pentameric IgM (pIgM) across mucosal epithelial cells to neutralize the invading respiratory pathogens. By studying the interaction between pIgR and SARS-CoV-2 proteins, we discovered that the viral accessory protein Open Reading Frame 8 (ORF8) potently downregulates pIgR expression and that this downregulation activity of ORF8 correlates with its ability to interact with pIgR. Importantly, the ORF8-mediated downregulation of pIgR diminishes the binding of dIgA or pIgM, and the ORF8 proteins of the variants of concern of SARS-CoV-2 preserve the function of downregulating pIgR, indicating the importance of this conserved activity of ORF8 in SARS-CoV-2 pathogenesis. We further observed that the secreted ORF8 binds to cell surface pIgR, but that this interaction does not trigger the cellular internalization of ORF8, which requires the binding of dIgA to pIgR. These findings suggest the role of ORF8 in SARS-CoV-2 mucosal immune evasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
- Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.
- Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
- Institut de Recherche Clinique de Montréal, Montreal, QC H2W 1R7, Canada.
Förderung
- CIHR
- Canadian Institutes of Health Research
- Canadian Institute of Health Research Canada Graduate Scholarship—Master’s program
- Fonds de Recherche du Québec Master’s Training Scholarship
Zitieren
APA
Laprise, F., Arduini, A., Duguay, M., Pan, Q., & Liang, C. (2024). SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR. Viruses. https://doi.org/10.3390/v16071008
Vancouver
Laprise F, Arduini A, Duguay M, Pan Q, Liang C. SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR. Viruses. 2024. doi:10.3390/v16071008
BibTeX
@article{Laprise2024,
author = {Laprise, Frederique and Arduini, Ariana and Duguay, Mathew and Pan, Qinghua and Liang, Chen},
title = {SARS-CoV-2 Accessory Protein ORF8 Targets the Dimeric IgA Receptor pIgR},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16071008}
}
EUVIMED